Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aee47d929abd9e5171fed4f170142fc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f453ee1366a8c7cdfa87d29ffe996a5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-763 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6acf3d04dc6c083a3ae0c2a6a88e97c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa3f733e09af5ba1744d8571996b32b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22d6ff493436385dcca5edd82d7b8907 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cfa045f76deb5ea547d7ceabe45a17a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_485b52018b41e05149d49fb090c25486 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e36bc51f03218b721615a6ba0d767ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e8b5301ad6b34bd533ac7150109ddd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48d2278c3e3cfa665c893c7f49ca506f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7bff18d222e551e871dee1947e8e124 |
publicationDate |
2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-102012003901-A2 |
titleOfInvention |
optical device for detection of specific marker of cardiac injury |
abstract |
The present invention relates to the manufacture of an optical device capable of detecting troponin macromolecule t which has a direct relationship with the cardiac lesion. The device is composed of a laser source that focuses a bioelectrode that becomes luminescent after recognizing the specific marker of cardiac injury. a photomultiplier coupled to a spectrometer amplifies this signal, which in turn is acquired by interfacing with a specific software whose output is expressed as luminescence in the form of a Gaussian curve where the peak is related on the abscissa axis with the characteristic wavelength of fluorophores. consisting of quantum dots and the ordinate axis with the concentration of troponin t. The making of the bioelectrode is made possible by modifying a vitreous electrode with a translucent polymeric film that covalently binds to the anti-troponin t antibody. Selective recognition of the troponin t heart injury marker by this bioelectrode is indirectly indicated by luminescence emission after additional high specificity couplings and can thus be used for diagnostic purposes. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022038586-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106768331-A |
priorityDate |
2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |